High materiality8/10
DexCom price target raised to $102 from $93 at Truist
Why it may matterVerify against the original reporting
Upside potential reinforced by higher target.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Truist raises DXCM price target to $102; current price $87.93; price +$1.61 since signal.
- Truist raises DXCM PT to $102; price $87.93.
Key facts
- 01
Target: $102
- 02
Posted price: $87.93
- 03
Analyst firm: Truist Financial
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.